AMSTERDAM — Children with short stature related to severe atopic dermatitis (AD) not only can have their condition effectively treated with 16 weeks of dupilumab but also may experience improved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback